Pi-Cardia

ShortCut Device Used to Treat a Patient Reported a Success

ShortCut is the world’s first dedicated device designed to split the leaflets of a pre-existing valve to enable safe Transcatheter Aortic Valve Replacement in patients at risk for coronary obstruction or compromised coronary access.

Venus Medtech to Partner with Pi-Cardia to Bring its Leaflex™ Aortic Valve Technology to China

Pi-Cardia's Leaflex™ catheter performs mechanical scoring of valve calcification, restoring leaflets' mobility and improving valve hemodynamics.